[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma].

Ishii, Kazuyoshi; Azuma, Yoshiko; Konishi, Akiko; Tsubokura, Yukie; Yoshimura, Hideaki; Hotta, Masaaki; Nakanishi, Takahisa; Nakaya, Aya; Fujita, Shinya; Satake, Atsushi; Miyaji, Michihiko; Ito, Tomoki; Nomura, Shosaku

Ishii, Kazuyoshi; Azuma, Yoshiko; Konishi, Akiko; Tsubokura, Yukie; Yoshimura, Hideaki; Hotta, Masaaki; Nakanishi, Takahisa; Nakaya, Aya; Fujita, Shinya; Satake, Atsushi; Miyaji, Michihiko; Ito, Tomoki; Nomura, Shosaku.

Afiliación

Ishii K; Department of Internal Medicine, Kansai Medical University.
Azuma Y; Department of Internal Medicine, Kansai Medical University.
Konishi A; Department of Internal Medicine, Kansai Medical University.
Tsubokura Y; Department of Internal Medicine, Kansai Medical University.
Yoshimura H; Department of Internal Medicine, Kansai Medical University.
Hotta M; Department of Internal Medicine, Kansai Medical University.
Nakanishi T; Department of Internal Medicine, Kansai Medical University.
Nakaya A; Department of Internal Medicine, Kansai Medical University.
Fujita S; Department of Internal Medicine, Kansai Medical University.
Satake A; Department of Internal Medicine, Kansai Medical University.
Miyaji M; Department of Internal Medicine, Kansai Medical University.
Ito T; Department of Internal Medicine, Kansai Medical University.
Nomura S; Department of Internal Medicine, Kansai Medical University.

Rinsho Ketsueki ; 59(8): 1002-1006, 2018.

Article en Ja | MEDLINE | ID: mdl-30185698

Asunto(s)

Enfermedad de Hodgkin/terapia; Inmunoconjugados/uso terapéutico; Trasplante de Células Madre; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Bleomicina/uso terapéutico; Brentuximab Vedotina; Ciclofosfamida/uso terapéutico; Doxorrubicina/uso terapéutico; Etopósido/uso terapéutico; Femenino; Humanos; Persona de Mediana Edad; Recurrencia Local de Neoplasia; Prednisona/uso terapéutico; Procarbazina/uso terapéutico; Trasplante Autólogo; Resultado del Tratamiento; Vincristina/uso terapéutico

Palabras clave

Autologous stem cell transplantation; Brentuximab vedotin; Classical Hodgkin lymphoma; Maintenance therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados / Trasplante de Células Madre Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: Ja Revista: Rinsho Ketsueki Año: 2018 Tipo del documento: Article Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google